WEC
ANIK icon

Winslow Evans & Crocker’s Anika Therapeutics ANIK Stock Holding History

Winslow Evans & Crocker’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$27K Buy
+590
New +$22.4K 0.01% 719

Other funds holding ANIK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Winslow Evans & Crocker's ANIK Position: Q4 2020 in Review

Winslow Evans & Crocker opened a new position in Anika Therapeutics (ANIK) in Q4 2020: 590 shares worth $27K. The stake represents 0.01% of the portfolio and ranks #719 among its holdings.

164 funds tracked by Wall St. Rank hold ANIK as of Q4 2020.

  • Winslow Evans & Crocker held 590 shares of Anika Therapeutics worth $27K as of Q4 2020.
  • Anika Therapeutics was a new Winslow Evans & Crocker position in Q4 2020.
  • Anika Therapeutics made up 0.01% of Winslow Evans & Crocker's portfolio in Q4 2020, its #719 holding.
  • 164 funds tracked by Wall St. Rank held Anika Therapeutics as of Q4 2020.

Based on Winslow Evans & Crocker's 13F filing for Q4 2020, filed 3 Feb 2021.